<--- Back to Details
First PageDocument Content
Immunosuppressants / Multiple myeloma / Hematology / Lenalidomide / International Myeloma Working Group / Bortezomib / Monoclonal gammopathy of undetermined significance / Dexamethasone / Thalidomide / Medicine / Health / Hematologic neoplasms
Date: 2012-04-18 11:56:07
Immunosuppressants
Multiple myeloma
Hematology
Lenalidomide
International Myeloma Working Group
Bortezomib
Monoclonal gammopathy of undetermined significance
Dexamethasone
Thalidomide
Medicine
Health
Hematologic neoplasms

International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantation

Add to Reading List

Source URL: myeloma.org

Download Document from Source Website

File Size: 217,70 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xHCw - View Document

PDF Document

DocID: 1xCqd - View Document

PDF Document

DocID: 1xxr4 - View Document

PDF Document

DocID: 1xfK3 - View Document

PDF Document

DocID: 1x8yx - View Document